These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 3005159)

  • 1. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.
    Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR
    Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
    Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
    Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
    Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
    Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
    Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
    Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.
    Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC
    Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
    Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
    Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.
    Collier AC; Barnes RC; Handsfield HH
    Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features.
    Bienzle U; Guggenmoos-Holzmann I; Zwingenberger K; Thommsen R; Ritter K; Uy A; Bayer H; Schneider J; Hunsmann G; Coester CH
    Klin Wochenschr; 1985 Jul; 63(13):597-602. PubMed ID: 2993734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
    Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M
    Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
    Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J
    Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
    AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
    Frazer IH; Sarngadharan MG; Mackay IR; Gallo RC
    Med J Aust; 1984 Sep; 141(5):274-6. PubMed ID: 6088957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.